de

Bitte wählen Sie Ihre Sprache

OECHSLER x PULMOTREE

Kolibri - Der Zerstäuber der Zukunft

Improved therapy through technical progress - A success story

Kolibri's project aims to address the weaknesses in respiratory care in Germany, as 10% of the population suffers from respiratory diseases, including asthma and COPD.

The project targets challenges such as uncontrolled particle deposition, high risks in clinical development, patient acceptance and adherence. OECHSLER & PULMOTREE aim to develop innovative solutions to optimize drug delivery, mitigate risks, and enhance patient experiences. This project is a testimony to OECHSLER’s pioneering spirit and paves the way for a brighter future in respiratory health through advancements in drug delivery technology.

We cooperate with OECHSLER in the field of design-for-manufacturing, development, and production of small and large series tools, and the production of components. In addition to the high-quality requirements, PULMOTREE has the ambition to develop and produce all products regionally as far as possible and all this in partnership rather than in a classical client-supplier relationship.

Ulf Krueger
CEO of PULMOTREE

We are delighted to stand beside PULMOTREE throughout the journey of developing Kolibri nebulizer. Leveraging the perfect blend of polymer injection molding and additive manufacturing, our unwavering support spans from ideation to series production. Being an integral part of this pioneering lung drug delivery innovation fills us with immense pride.

Felix Hess
SVP Business Unit Health

Use Case Herunterladen

Your Name

Please enter your full name.

Please enter your email so we can get in touch.

Please enter your comments.